BENITEC BIOPHARMA INC (BNTC): Institutional Ownership

Hedge funds and institutional managers reporting a position in BNTC · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
7
13F filers
Aggregate Value
$35.0M
Across holders
Last Price
$12.37
2026-06-26
Sector
Health Care
GICS
Holder activity2 new3 added1 reduced
Institutional Holders of BNTC
7 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 0001165408
Hedge Fund2.12M$22.6M64.4%0.0%Unchanged+$0Q1 2026
BALYASNY ASSET MANAGEMENT LLC
CIK 0001218710
Hedge Fund654K$7.0M19.9%0.0%Added+$24KQ1 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund172K$1.8M5.2%0.0%Added+$1.6MQ1 2026
Schonfeld Strategic Advisors LLC
CIK 0001665241
Hedge Fund153K$1.6M4.7%0.0%Reduced$-1.2MQ1 2026
ExodusPoint Capital Management, LP
CIK 0001736225
Hedge Fund78K$1.1M3.1%0.0%NewQ3 2025
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund72K$765K2.2%0.0%Added+$385KQ1 2026
Brevan Howard Capital Management LP
CIK 0001512857
Hedge Fund17K$177K0.5%0.0%NewQ1 2026
BNTC Institutional & Hedge Fund Ownership | HedgeFundIntel